Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in the management of hepatocellular carcinoma
K. Nathan Sankar, Jun Gong, Arsen Osipov, et al.
Clinical and Molecular Hepatology (2023) Vol. 30, Iss. 1, pp. 1-15
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Organoids and spheroids: advanced in vitro models for liver cancer research
Mirella Pastore, A. Giachi, Elena Spínola-Lasso, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
Theodoros Pettas, Sofia Lachanoudi, Filippos F. Karageorgos, et al.
World Journal of Transplantation (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 1
Mechanisms of Targeted Drug Delivery for Liver Cancer: Active, Passive, and Subcellular Strategies
Tian Yang, Yu-Sheng Shi
Journal of Biosciences and Medicines (2025) Vol. 13, Iss. 02, pp. 369-384
Open Access | Times Cited: 1
Case Report: Posterior reversible encephalopathy syndrome after lenvatinib treatment for hepatocellular carcinoma
Minchun Chen, Jing Shen, Rongrong Jia, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 7
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
Linda Galasso, Lucia Cerrito, Valeria Maccauro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7191-7191
Open Access | Times Cited: 6
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 807-823
Open Access | Times Cited: 5
Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Jiwon Hong, Jung Woo Eun, Geum Ok Baek, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 360-374
Open Access | Times Cited: 4
Artemyriantholidimers A-G, undescribed guaiane-type sesquiterpenoid dimers from Artemisia myriantha and their antihepatoma activities
Mengfei Wang, Tian-Ze Li, Yun‐Bao Ma, et al.
Phytochemistry (2025) Vol. 233, pp. 114409-114409
Closed Access
The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies
Shuairan Zhang, Dong Hang, Xiuli Jin, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167676-167676
Closed Access
Artificial intelligence-assisted platform performs high detection ability of hepatocellular carcinoma in CT images: an external clinical validation study
Rongxue Shan, Chenhao Pei, Qianrui Fan, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Celecoxib as a Potential Treatment for Hepatocellular Carcinoma in Populations Exposed to High PFAS Levels
Boshi Sun, Yuqiao Zhao, Shifeng Yang, et al.
Journal of Hazardous Materials (2025) Vol. 489, pp. 137613-137613
Closed Access
Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Changcheng Tao, Liguo Liu, Nan Hu, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 261-274
Open Access
Exosome biosensors for detection of liver cancer
Asma Vafadar, Mohammad Younesi, Sepideh Babadi, et al.
Clinica Chimica Acta (2025), pp. 120199-120199
Closed Access
Evolving Transplant Oncology: Evolving Criteria for Better Decision-Making
Filippos F. Karageorgos, Konstantina-Eleni Karakasi, Athanasios Kofinas, et al.
Diagnostics (2025) Vol. 15, Iss. 7, pp. 820-820
Open Access
Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis
Jinxiang Peng, Haozhu Chen, Zhuang Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Statistical Cure After Hepatectomy for Hepatitis B Virus-Associated Hepatocellular Carcinoma: A Risk-Stratification Model
Yifan Li, Lan‐Qing Yao, Chao Li, et al.
Annals of Surgical Oncology (2025)
Closed Access
Hepatobiliary Cancers in Saudi Arabia From 2000 to 2025
Khalil Alshammari, Ibrahim Ginawi, Hisham Sherfi, et al.
Cureus (2025)
Open Access
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma
LI Ji-pin, Yong Tao, Yali Chen, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma
Kaiming He, Desheng Chen, Dunru Zhu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
B cell receptor repertoire signature as a diagnostic biomarker for hepatocellular carcinoma
Zixue Xuan, Qiang Ye, Guobing Zhang, et al.
Asian Journal of Surgery (2025)
Open Access
Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
Ye Rim Kim, Sung Won Chung, Min-Ju Kim, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1235-1249
Open Access | Times Cited: 3
CAF-derived miR-642a-3p supports migration, invasion, and EMT of hepatocellular carcinoma cells by targeting SERPINE1
Shuo Zhang, Gang Cao, Shuijie Shen, et al.
PeerJ (2024) Vol. 12, pp. e18428-e18428
Open Access | Times Cited: 3
SERPINH1 secretion by cancer-associated fibroblasts promotes hepatocellular carcinoma malignancy through SENP3-mediated SP1/SQLE pathway
Hua Xiao, Zhaoying Yao, Tao Li, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114259-114259
Closed Access
Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jeayeon Park, Su Jong Yu
The Ewha Medical Journal (2025) Vol. 48, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top